CEGEDIM |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 13.75 EUR | +1.85% |
|
-0.72% | -23.01% |
| Apr. 26 | Cegedim: 7% sales growth in Q1 | CF |
| Apr. 25 | Transcript : Cegedim SA, Q1 2024 Sales/ Trading Statement Call, Apr 25, 2024 |
Presenter SpeechJean-Claude Labrune (Executives)Good evening, and good morning everyone. And t...
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe
Cegedim is a European leading in collecting, processing, and distributing data and services related to medical information. Net sales break down by market as follows:
- Insurance companies and services (72.1%): computerization of insurers and mutual benefit insurance companies, management of third-party payers and health care trends, external human resources management, computer and Internet services, etc. The group also develops processing sales statistics of pharmaceutical products, management of medical samples and promotional materials activities, etc. (GERS);
- Health care professionals (26.8%): software for physicians and pharmacists, pharmaceutical data base, scientific, medical, and promotional information, etc.;
- other (1.1%).
France accounts for 89.7% of net sales.
Sector
Software
Calendar
2024-06-14
- Shareholders Meeting
Trading Rating
Investor Rating
ESG Refinitiv
C+
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
4
Last Close Price
13.75
EUR
Average target price
19.37
EUR
Spread / Average Target
+40.85%
EPS Revisions
Quarterly revenue - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -23.01% | 200M | |
| +11.17% | 322B | |
| +24.75% | 216B | |
| +2.41% | 149B | |
| +10.65% | 56.27B | |
| +8.71% | 32.13B | |
| -4.57% | 27.45B | |
| +103.03% | 22.62B | |
| +20.22% | 19.55B | |
| +0.04% | 14.61B |
- Stock Market
- Equities
- CGM Stock
- News Cegedim
- Transcript : Cegedim SA, H1 2022 Earnings Call, Sep 20, 2022
